Edward Karol Sikora

Edward Karol Sikora is the founder of Genesis Cancer Care UK Ltd. (founded in 2006) and Rutherford Health Plc (founded in 2015), where he holds the title of Chief Medical Officer and Director & Chief Medical Officer respectively.
He currently holds positions as Chairman at Venomtech Ltd., Director at The MEI Healthcare Group LLC, Director at Rutherford Diagnostics Ltd., Director at Rutherford Cancer Care Ltd., Director at Transcrip Partners LLC, Director at Cancerpartners International Ltd., and Dean & Professor at the University of Buckingham.
Dr. Sikora's former positions include Chairman-Cancer Medicine Department at Imperial College School of Medicine, Scientific Director at Source BioScience Ltd., Director at Weifa ASA (2007-2012), Clinical Director-Cancer Services at Hammersmith Hospitals (1985-1997), Deputy Director-Clinical Research at Imperial Cancer Research Fund Trading Ltd. (1997-1999), Director at Cancer Treatment Partners International Ltd., Director at Dorset Square Oncology Ltd., Director at Mei Healthcare Ltd., Director at Protonpartnersuk Ltd., Professor at Imperial College London, and VP-Global Clinical Research at Pharmacia Corp.
(1999-2002).
Dr. Sikora's education includes a doctorate from Stanford University and an undergraduate degree from the University of Cambridge.